Back to News

H.C. Wainwright 22nd Annual Global Investment Conference – Virtual Conference

Bernard Gilly, Chief Executive Officer and Thomas Gidoin, Chief Financial Officer will participate to the H.C. Wainwright 22nd Annual Global Investment Conference and will host investor meetings.

Bernard Gilly, Chief Executive Officer, will present on Wednesday, September 16th, 2020 at 1:00 p.m. ET (7.00pm CET).

Back to News

A New Chapter

Founded in 2012 to realize the potential of gene therapy, GenSight Biologics has grown into a clinical-stage company advancing multiple programs. In 2024, under a new management team, the company entered a new phase and is now accelerating its clinical and regulatory activities.

Explore investors’ hub

GenSight Biologics S.A.
74 rue du Faubourg Saint-Antoine
75012 Paris
France